logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
31/07/2025
Spot platinum just broke through the $1380.00 per ounce level, currently trading at $1379.45 per ounce, down 0.81% on the day; Nymex platinum futures are currently trading at $1410.2 per ounce, down 0.66% on the day.
Latest
1 m ago
Shenzhen: By the end of 2026, it will have built 10 low-altitude economic industrial parks and 2 characteristic industrial parks, covering technology research and development, production manufacturing, marketing and display formats.
2 m ago
Hong Kong stocks are fluctuating | Wescott Group (00856.HK) rises more than 3% during trading, the company's Southeast Asian business is diversifying its layout. Institutions believe that its current valuation has significant upside potential.
2 m ago
Hong Kong stocks are abnormal | AI concept stocks are strong, and recent AI applications have multiple catalysts. Institutions say that the second half of the year, AI is the main investment opportunity.
2 m ago
Stocks in Hong Kong are moving differently, with Kangfang Biotech (09926.HK) rising nearly 5% to hit a new high. The first dose of the Yivosei joint treatment plan for treating IO-resistant NSCLC in Phase III clinical trials has been completed.
3 m ago
Shenzhen: By the end of 2026, the low-altitude economic headquarters R&D testing overall layout of "1+5+4" will be completed, and the output value scale will exceed 130 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.